TLSI TriSalus Life Sciences Inc
228
$9.97
$0.18
(1.77%)
| Watchers | 228 |
| 52-Wk Low | $3.32 |
| 52-Wk High | $16.24 |
| Market Cap | $270.78M |
| Volume | 2,983.00 |
| 52-Wk High | $16.24 |
| 52-Wk Low | $3.32 |
TriSalus Reports Q1 2024 Financial Results and Business UpdateBusiness Wire • 7 days ago
TriSalus Life Sciences Inc., (Nasdaq: TLSI), today announced its financial results for the first quarter ended March 31, 2024, and provided a business update. Im proud to highlight our strong start...
Share to Feed
TriSalus Life Sciences Inc. (Nasdaq: TLSI), an oncology company integrating its novel delivery technology with immunotherapy to transform treatment for patients with liver and pancreatic tumors...
TriSalus Life Sciences Inc., (Nasdaq: TLSI), an oncology company integrating its novel delivery technology with immunotherapy to transform treatment for patients with liver and pancreatic tumors...
TriSalus Life Sciences Inc., (Nasdaq: TLSI), today announced the closing of a debt financing facility for up to $50 million with OrbiMed, a healthcare investment firm. The capital is expected to...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
TriSalus Life Sciences Inc., (Nasdaq: TLSI), today announced its financial results for the fourth quarter and full year ended December 31, 2023, and provided a business update. 2023 was a critical...
TriSalus Life Sciences, Inc. (TLSI) Q4 2023 Earnings Call Transcript...
TriSalus Surpasses Revenue Estimates but Faces Net Loss Wider Than ExpectedRelated Stocks: TLSI...
Technology from TriSalus Life Sciences Inc. (Nasdaq: TLSI), an oncology company integrating its novel delivery technology with immunotherapy to transform treatment for patients with liver and...
TriSalus Life Sciences Inc. (Nasdaq: TLSI), an oncology company integrating its novel delivery technology with immunotherapy to transform treatment for patients with liver and pancreatic tumors...